ArticleMedical sciences (Basel, Switzerland)2024

Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression.

Ilya TsimafeyeuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.